Galmed Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -2,074 | -2,109 | -1,264 | |
EBIT | -2,095 | -3,209 | ||
Net Income | -1,892 | -2,495 | -1,104 | -3,209 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -1,935 | -1,268 | -1,167 | -1,969 |
Cash | 3,314 | 4,964 | 4,767 | 4,652 |
Basic Shares | 5,460 | 3,948 | 1,779 | 1,664 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -83 | -31 | -35 | -42 |
EBITDA | -7,419 | -6,870 | -17,616 | -32,839 |
EBIT | -7,502 | -6,901 | -17,651 | -32,881 |
Net Income | -7,517 | -6,912 | -18,571 | -31,948 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -5,880 | -6,137 | -18,505 | -32,903 |
Cash | 4,652 | 2,861 | 2,016 | 2,884 |
Basic Shares | 930 | 230 | 1,676 | 1,639 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-09-30 | -$0.33 |
2025-06-30 | -$0.63 |
2025-03-31 | -$0.62 |
